157 related articles for article (PubMed ID: 12779075)
1. Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions.
Zullo A; Hassan C; Morini S
Dig Liver Dis; 2003 Mar; 35(3):197-205. PubMed ID: 12779075
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence and role of Helicobacter pylori infection in some gastroduodenal and hepatic complications in cirrhotic patients].
Săndulache L; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):890-5. PubMed ID: 20209758
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication.
Vásconez C; Elizalde JI; Llach J; Ginès A; de la Rosa C; Fernández RM; Mas A; Santamaría J; Bordas JM; Piqué JM; Terés J
J Hepatol; 1999 Feb; 30(2):260-4. PubMed ID: 10068106
[TBL] [Abstract][Full Text] [Related]
4. Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection.
Dasani BM; Sigal SH; Lieber CS
Am J Gastroenterol; 1998 May; 93(5):726-31. PubMed ID: 9625117
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
[TBL] [Abstract][Full Text] [Related]
6. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
7. Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication.
Agrawal A; Gupta A; Chandra M; Koowar S
Indian J Gastroenterol; 2011 Feb; 30(1):29-32. PubMed ID: 21416318
[TBL] [Abstract][Full Text] [Related]
8. [Peptic ulcer disease in liver cirrhosis: role of Helicobacter pylori infection and therapeutic approach].
Mitrică D; Constantinescu R; Drug VL; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):27-32. PubMed ID: 21688556
[TBL] [Abstract][Full Text] [Related]
9. CagA status and Helicobacter pylori eradication among dyspeptic patients.
Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
[TBL] [Abstract][Full Text] [Related]
10. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori and liver: an actor with three roles?
Ponzetto A; Fagoonee S; Pellicano R
Dig Liver Dis; 2001; 33(5):399-401. PubMed ID: 11529649
[No Abstract] [Full Text] [Related]
12. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review.
Schulz C; Schütte K; Malfertheiner P
J Clin Gastroenterol; 2014 Jul; 48(6):491-9. PubMed ID: 24583758
[TBL] [Abstract][Full Text] [Related]
13. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].
Wang LJ; Cai JT; Chen T; Lü B; Si JM
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):654-7. PubMed ID: 17074151
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and hepatic encephalopathy.
Duseja A; Sachdev A; Dhiman RK; Chawla YK
Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S31-2. PubMed ID: 15025251
[TBL] [Abstract][Full Text] [Related]
15. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.
Chan FK; Sung JJ; Suen R; Lee YT; Wu JC; Leung WK; Chan HL; Lai AC; Lau JY; Ng EK; Chung SC
Aliment Pharmacol Ther; 1998 Dec; 12(12):1201-5. PubMed ID: 9882027
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Helicobacter pylori Infection in Patients with Minimal Hepatic Encephalopathy.
Schulz C; Schütte K; Reisener N; Voss J; Malfertheiner P
J Gastrointestin Liver Dis; 2016 Jun; 25(2):191-5. PubMed ID: 27308650
[TBL] [Abstract][Full Text] [Related]
17. [Role of anti-secretory treatment in addition to Helicobacter pylori eradication triple therapy in the treatment of peptic ulcer].
Jung JM; Shim KN; Oh HJ; Na YJ; Jung HS; Jung SA; Yoo K
Korean J Gastroenterol; 2008 Jan; 51(1):11-8. PubMed ID: 18349557
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
Hawkey CJ; Atherton JC; Treichel HC; Thjodleifsson B; Ravic M
Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
